§ Claim under review · Study
"Higher magnesium intake is associated with larger brain volume and slower brain aging, especially in women, according to a study published in European Journal of Nutrition (DOI: 10.1007/s00394-023-03123-x)" Accompanying caption claims investigated: UK Biobank sample of over 6,000 adults; larger brain volumes and fewer white matter lesions; roughly one year of preserved brain aging between typical and high intake; effect strongest in women and stronger after menopause, opposite to prediction; blood pressure ruled out as mechanism; inflammation as likely mechanism; observational design.
Verdict
Mostly accurate
Confidence
HighSummary
The study in this post is real and correctly cited. Researchers at the Australian National University analysed 6,001 UK Biobank adults aged 40 to 73 and found that people reporting higher dietary magnesium intake had slightly larger grey matter and hippocampal volumes on MRI, with the association more consistent in women and, unexpectedly, stronger in women past menopause. The authors themselves calculated that eating 550 mg a day rather than a typical 350 mg corresponded to roughly one year of brain ageing, which in raw terms is about 0.2 percent more grey matter. Three details in the post do not hold up. Higher magnesium was linked to fewer white matter lesions in men, but at baseline the direction in women was slightly the other way, so pairing "fewer lesions" with "strongest in women" is wrong. Saying the data "ruled out" blood pressure overstates a finding that was simply not statistically significant, and the inflammation mechanism comes from a separate 2024 paper by the same team, not the study cited. This was an observational study using a single-day diet questionnaire, so it cannot show that taking more magnesium would change anyone's brain.
The readings
key figures from the evidenceUK Biobank sample size in the study
brain ageing equivalent between 350 and 550 mg/day intake
larger grey matter volume at top quartile magnesium intake
Why this verdict
Evidence
The cited study is real, correctly attributed, and the DOI is accurate. Participants aged 40 to 73 from UK Biobank (n = 6001) were included and stratified by sex, with dietary magnesium measured using an online computerised 24 hour recall questionnaire to estimate daily intake. On average, higher baseline dietary magnesium intake was associated with larger brain volumes (gray matter: 0.001%; left hippocampus: 0.0013%; right hippocampus: 0.0023%) in both men and women.
These are per-milligram coefficients, so the absolute differences across realistic intake ranges are small.
On the "one year" figure, the authors wrote that compared with somebody with a normal magnesium intake of about 350 mg/day, somebody in the top quartile of intake (at or above 550 mg/day) would be predicted to have about 0.20% larger grey matter and about 0.46% larger right hippocampus, and in a population with an average age of 55 years this effect corresponds to about 1 year of typical ageing . They added that if the effect is generalisable to other populations, a 41% increase in magnesium intake may lead to significantly better brain health.
On sex and menopause, the paper's conclusion was that higher dietary magnesium intake is related to better brain health in the general population, and particularly in women . The menopause result was genuinely contrary to the authors' stated expectation: they predicted the association between higher magnesium intake and larger brain volumes would be greater in pre-menopausal women, because magnesium contributes to regulation of healthy estrogen levels and is important for preventing hypertension, improving insulin sensitivity and reducing cardio-metabolic risk factors, but this was not supported by their results, which showed a stronger association in post-menopausal women across several brain regions .
On mechanism, associations between magnesium and blood pressure measures were mostly non-significant . The same group later wrote that contrary to expectations, their findings did not support a blood-pressure-lowering effect as the main mechanism mediating the relationship between magnesium and cerebral health, suggesting other mechanisms may be involved .
Findings
✓ What's accurate 8
- The journal, authors, title and DOI are all correct. This is a real, open-access, peer-reviewed paper.
- The sample description is accurate: UK Biobank, n = 6001, aged 40 to 73.
- Higher baseline dietary magnesium was associated with larger grey matter and hippocampal volumes in both sexes.
- The "roughly one year of brain aging" figure is the authors' own stated interpretation, not an invention of the post, and the 350 versus 550 mg/day comparison is the correct anchor.
- The paper's own conclusion does state the relationship is particularly evident in women.
- The post-menopause finding really was opposite to the authors' pre-stated prediction. This is an unusually faithful detail for a social media post.
- Blood pressure associations really were mostly non-significant, and the authors themselves later described the blood pressure mechanism as unsupported.
- The post correctly states that this is observational and not a clinical trial, which most viral versions of this study omit.
≈ What's misleading 6
- Directional error on white matter lesions combined with the sex claim. The post says higher intake was linked to "fewer white matter lesions" and that "the finding was strongest in women." In the baseline analysis, the lesion direction split by sex: every 1 mg higher baseline magnesium above 350 mg/day was associated with 0.001% lower white matter lesions in men, and with 0.0012 larger white matter lesions in women . The abstract's headline baseline result lists only grey matter and hippocampal volumes, not lesions. The lesion signal in women came from the trajectory comparison, where the low-increasing class had larger lesions. Distortion type: omitted qualifier plus subgroup conflation. A reader would take away that magnesium reduces lesions most in women, which is the opposite of the baseline female result.
- "Which the data ruled out." The paper reported associations that were mostly non-significant and concluded mediation was unsupported. That is failure to find evidence for a mechanism, not elimination of it, particularly given a crude single-day dietary exposure measure and a short follow-up window. Distortion type: exaggeration of certainty.
- Mechanism attributed to the wrong paper. Inflammation as the operative mechanism was a hypothesis in the 2023 paper, not a finding. It was tested in a separate 2024 paper by the same team using different markers and mediation analysis. The post presents the inflammation conclusion as if it came from the cited study. The underlying substance is defensible, but the citation does not support it. Distortion type: source-claim mismatch.
- The strange shape of the protective signal is omitted. In women the significant benefit sat in the "high-decreasing" trajectory, meaning intake that started high and fell, not intake that was consistently high. Under 2 percent of women were in that class. The menopause interaction lives entirely inside that tiny subgroup. Presenting this as a clean "eat more magnesium" message omits the fact that the trajectory pattern does not straightforwardly support that reading. Distortion type: subgroup generalisation and omitted qualifier.
- Effect magnitude is invisible in the post. About 0.20 percent larger grey matter volume is the underlying number behind "roughly a year." The "one year of brain aging" framing is a modelled cross-sectional translation, not an observed longitudinal difference in anyone's brain ageing rate. The post's phrase "a year of preserved brain aging" implies something was preserved over time. Nothing was tracked over time here. Distortion type: temporal overreach.
- The 550 mg/day threshold is above the recommended intake range of roughly 310 to 420 mg/day and above the cohort's own average. "High intake" in this study means substantially above standard guidance, which the post's "how easily modifiable diet actually is" framing understates.
? What's uncertain 4
- Whether raising magnesium intake changes brain structure in any individual. No randomised trial evidence is cited or invoked, and the design cannot establish causation. Higher dietary magnesium tracks closely with overall diet quality, leafy greens, nuts, whole grains, socioeconomic status and other unmeasured or imperfectly measured confounders.
- Whether the sex difference is a real biological effect or an artefact of statistical significance thresholds. The paper reports associations in both sexes; significance was more consistent in women. "Strongest in women" is the authors' framing, but a difference in significance is not the same as a demonstrated difference in effect.
- The robustness of the menopause interaction, given the very small class size. The paper itself uses hedged language ("appears to be greater").
- Whether the post's own newsletter breakdown, referenced but not accessible here, adds or corrects any of these caveats. Only the caption and image text were assessed.
Sources
5 of 6 linked to recordsAlateeq K, Walsh EI, Cherbuin N. "Dietary magnesium intake is related to larger brain volumes and lower white matter lesions with notable sex differences." European Journal of Nutrition 2023;62(5):2039-2051
Alateeq K, Walsh EI, Ambikairajah A, Cherbuin N. "Association between dietary magnesium intake, inflammation, and neurodegeneration." Eur J Nutr 2024;63(5):1807-1818
ANU institutional press release, "Eating more magnesium each day keeps dementia at bay," March 2023
Medscape coverage quoting the authors' own effect-size interpretation
Medical News Today, New Atlas, Neuroscience News, ScienceDaily, Fisher Center